• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Updates, 23-01-2026: Press Release

    23-01-2026 | 08:21 am

    Sun Pharma secured approval for its generic semaglutide injection, Noveltreat, for chronic weight management in India. It will launch post-patent expiry, adding to its approved diabetes version (Sematrinity). This targets significant public health needs.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited